Raffles Medical jumps 6.7% on 100 million share buyback plan; posts 4.3% rise in H2 profit to S$31.6 million
The board proposes a final dividend of S$0.025 per ordinary share
Add BT as a preferred source
PRIVATE healthcare provider Raffles Medical Group posted a 4.3 per cent rise in net profit to S$31.6 million for its second half ended Dec 31, 2024, from S$30.3 million in the previous corresponding period.
The group also intends to buy back up to 100 million shares, representing 5.3 per cent of its total ordinary issued shares, over the next two years, it said in a bourse filing on Monday (Feb 24).
Following the news, the counter jumped 6.7 per cent to peak at S$0.88 as at 10.24 am, and closed at this price on Monday.
TRENDING NOW
Qatari LNG ship struck in Strait of Hormuz, testing US talks
DBS shares rise 1.9% to hit all-time intraday high as sentiment improves
‘Baptism of fire’: Andre Khor on leading Singapore refiner Aster through an energy crisis
Singapore retains top spot as most expensive city for HNWIs, with five Apac cities in global top 10
